FTSE 100 down 36 points at 7,476 Food price inflation drops to 9.1%, says Kantar Barclays slips as Qatar wealth fund cuts ...

AbbVie is buying ImmunoGen in a deal valued at about $10.1 billion with the goal of speeding the pharmaceutical's entry into the commercial market for ovarian cancer. ImmunoGen Inc. has the ovarian ...